Aramis Biotechnologies and the Biologics Manufacturing Centre (BMC) Inc. announce the successful delivery of a seasonal influenza vaccine in development
Aramis Biotechnologies Inc. (“Aramis”), a Canadian company pioneering and a global leader in…
The release of the Quebec budget in March confirmed a number of positive trends for our industry, but also revealed…
March was marked by an eagerly awaited milestone: the presentation of the 2025-2026 budget by Minister Éric Girard.
The year 2025 is evolving in an unstable and unpredictable economic and political environment likely to force strategic adjustments in…
Navigating uncertainty: impacts and adaptations for our sector
Together towards 2025: challenges and opportunities
2024 in retrospect
We have just started the 2025 Renewal Campaign!
September was a month rich in events and twists and turns.
The BIOQuébec team has been particularly active in recent weeks, preparing for a back-to-school season full of projects and…
Aramis Biotechnologies Inc. (“Aramis”), a Canadian company pioneering and a global leader in…
We use cookies to improve your browsing experience and analyze our traffic. By clicking "Accept", you consent to our use of cookies.
Privacy Policy